World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
60
Citations
10478
World Ranking
3897
National Ranking
1769

Overview

Ivan Bodis-Wollner is affiliated with SUNY Downstate Medical Center in the United States. Their research primarily focuses on the study of neurological disorders with an emphasis on Parkinson's disease mechanisms and treatments. The body of work spans fields including Medicine, Biochemistry, Genetics and Molecular Biology, with notable specialization in Neurology and Molecular Biology.

The scientist's contributions cover several specialized subfields such as Neurology, Physiology, Molecular Biology, Cognitive Neuroscience, and Complementary and Alternative Medicine. Key research topics addressed include Parkinson's Disease Mechanisms and Treatments, Adenosine and Purinergic Signaling, RNA Regulation and Disease, Autism Spectrum Disorder Research, Botulinum Toxin and Related Neurological Disorders, Ginkgo biloba and Cashew Applications, as well as Antioxidant Activity and Oxidative Stress.

Ivan Bodis-Wollner has published work in multiple respected scientific journals. The frequent publication venues include:

  • JAMA
  • Parkinsonism & Related Disorders
  • Journal of Neural Transmission

Some recent notable papers authored or co-authored by them are:

  • Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression, 2021, JAMA
  • Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies, 2022, Parkinsonism & Related Disorders
  • The intrinsically restructured fovea is correlated with contrast sensitivity loss in Parkinson's disease, 2020, Journal of Neural Transmission

Throughout their career, Ivan Bodis-Wollner has collaborated frequently with other researchers. Prominent co-authors with multiple joint publications include:

  • Rajeev Kumar
  • Joseph H. Friedman
  • Kelvin L. Chou
  • Ariane Park
  • S. Elizabeth Zauber

Best Publications

  • VISUAL DEFICITS RELATED TO DOPAMINE DEFICIENCY IN EXPERIMENTAL ANIMALS AND PARKINSON'S DISEASE PATIENTS

    I. Bodis-Wollner

  • Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity.

    Ivan Bodis-Wollner;Marcia S. Marx;Sunanda Mitra;Phyllis Bobak

  • A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit

    M Flint Beal;David Oakes;Ira Shoulson

  • Inner retinal layer thinning in Parkinson disease.

    Mohammedyusuf E. Hajee;Wayne F. March;Douglas R. Lazzaro;Arthur H. Wolintz

  • Visual Acuity and Contrast Sensitivity in Patients with Cerebral Lesions

    Ivan Bodis-Wollner

  • Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial

    Tanya Simuni;Karl Kieburtz;Barbara Tilley;Jordan J Elm

  • Abnormalities of Central Contrast Sensitivity in Glaucoma

    Adam Atkin;Ivan Bodis-Wollner;Murray Wolkstein;Alan Moss

  • THE MEASUREMENT OF SPATIAL CONTRAST SENSITIVITY IN CASES OF BLURRED VISION ASSOCIATED WITH CEREBRAL LESIONS

    Ivan Bodis-Wollner;Sidney P. Diamond

  • Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease A Randomized Clinical Trial

    Karl Kieburtz;Barbara C. Tilley;Jordan J. Elm;Debra Babcock

  • α‐synuclein in the inner retina in parkinson disease

    Ivan Bodis-Wollner;Piotr B. Kozlowski;Sofya Glazman;Shahnaz Miri

  • Visual Association Cortex and Vision in Man: Pattern-Evoked Occipital Potentials in a Blind Boy

    Ivan Bodis-Wollner;Adam Atkin;Edward Raab;Murray Wolkstein

  • Dopaminergic deficiency and delayed visual evoked potentials in humans.

    Ivan Bodis-Wollner;Melvin D. Yahr;Leland Mylin;John Thornton

  • Neuropsychological and perceptual defects in Parkinson's disease.

    Ivan Bodis-Wollner

  • Pattern Electroretinograms and Visual-Evoked Potentials in Glaucoma and Multiple Sclerosis

    P. Bobak;I. Bodis-Wollner;S. Podos;C. Harnois

  • Retinopathy in Parkinson disease

    Ivan Bodis-Wollner

  • Cortical binocularity in infants

    Oliver Braddick;Janette Atkinson;Bela Julesz;Walter Kropfl

  • Contrast Sensitivity in Retinal Disease

    Murray Wolkstein;Adam Atkin;Ivan Bodis-Wollner

  • Visual evoked potentials and the visuogram in multiple sclerosis

    Ivan Bodis‐Wollner;Charles D. Hendley;Leland H. Mylin;John Thornton

  • Functional MRI mapping of occipital and frontal cortical activity during voluntary and imagined saccades

    I. Bodis-Wollner;S. F. Bucher;K. C. Seelos;W. Paulus

  • The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning.

    Michele Tagliati;Michele Tagliati;Ivan Bodis-Wollner;Melvin D. Yahr

  • The push–pull action of dopamine on spatial tuning of the monkey retina: the effects of dopaminergic deficiency and selective D1 and D2 receptor ligands on the pattern electroretinogram.

    I Bodis-Wollner;A Tzelepi

Frequent Co-Authors

Marco Onofrj
Marco Onofrj University of Chieti-Pescara
Michael J. Aminoff
Michael J. Aminoff University of California, San Francisco
Maria Felice Ghilardi
Maria Felice Ghilardi City University of New York
Ivan W. Selesnick
Ivan W. Selesnick New York University
Andrea Antal
Andrea Antal University of Göttingen
Michael S. Okun
Michael S. Okun University of Florida
Catherine C. Price
Catherine C. Price University of Florida
Jay S. Schneider
Jay S. Schneider University of Pennsylvania
Joan C. Borod
Joan C. Borod City University of New York
Paolo Stanzione
Paolo Stanzione University of Rome Tor Vergata

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Ivan Bodis-Wollner

Trending Scientists

Recently Published Articles